IRF4-Dependent Cell Proliferation Is a Potential Therapeutic Target in Peripheral T-Cell Lymphomas

被引：0
|
作者：
Feldman, A. L. [1 ]
Wilcox, R. A. [1 ]
Porcher, J. [1 ]
Dogan, A. [1 ]
Ansell, S. M. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1322
引用
收藏
页码：295A / 295A
页数：1
相关论文
共 50 条
  • [41] Novel therapies in peripheral T-cell lymphomas
    O'Leary H.M.
    Savage K.J.
    Current Hematologic Malignancy Reports, 2008, 3 (4) : 213 - 220
  • [42] Pathology and pathophysiology of peripheral T-cell lymphomas
    Gaulard, P.
    de Leval, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S6 - S7
  • [43] Peripheral T-cell lymphomas: diagnosis and management
    Dearden, CE
    Foss, FM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (06) : 1351 - +
  • [44] ABERRANT PHENOTYPES IN PERIPHERAL T-CELL LYMPHOMAS
    HASTRUP, N
    RALFKIAER, E
    PALLESEN, G
    JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (04) : 398 - 402
  • [45] Molecular genetics of peripheral T-cell lymphomas
    Piccaluga, Pier Paolo
    Tabanelli, Valentina
    Pileri, Stefano A.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (03) : 219 - 226
  • [46] Novel Therapies in Peripheral T-Cell Lymphomas
    O'Leary, Hilary M.
    Savage, Kerry J.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 404 - 411
  • [47] THE PROGNOSTIC FACTORS FOR PERIPHERAL T-CELL LYMPHOMAS
    LIANG, R
    LOKE, SL
    CHAN, ACL
    HEMATOLOGICAL ONCOLOGY, 1992, 10 (3-4) : 135 - 140
  • [48] BELINOSTAT FOR THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMAS
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (05) : 337 - 345
  • [49] INTENSIVE CHEMOTHERAPY FOR PERIPHERAL T-CELL LYMPHOMAS
    LIANG, R
    TODD, D
    CHAN, TK
    CHIU, E
    LIE, A
    HO, FCS
    LOKE, SL
    HEMATOLOGICAL ONCOLOGY, 1992, 10 (3-4) : 155 - 161
  • [50] Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
    Orlova, Anna
    Wingelhofer, Bettina
    Neubauer, Heidi A.
    Maurer, Barbara
    Berger-Becvar, Angelika
    Keseru, Gyorgy Miklos
    Gunning, Patrick T.
    Valent, Peter
    Moriggl, Richard
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (01) : 45 - 57
12345